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Polycystin-1embryonic and postnatal growth of the craniofacial bones and the skull base is
essential during the expansion of the rostrum and the brain. Identiﬁcation of molecules that regulate skull
growth is important for understanding the nature of craniofacial defects and for development of non-
invasive biologically based diagnostics and therapies.
Here we report on spatially restricted growth defects at the skull base and in craniofacial sutures of mice
deﬁcient for polycystin-1 (Pkd1). Mutant animals reveal a premature closure of both presphenoid and
sphenooccipital synchondroses at the cranial base. Furthermore, knockout mice lacking Pkd1 in neural crest
cells are characterized by impaired postnatal growth at the osteogenic fronts in craniofacial sutures that are
subjected to tensile forces. Our data suggest that polycystin-1 is required for proliferation of subpopulations
of cranial osteochondroprogenitor cells of both mesodermal and neural crest origin during skull growth.
However, the Erk1/2 signalling pathway is up-regulated in the Pkd1-deﬁcient skeletal tissue, similarly to that
previously reported for polycystic kidney.
© 2008 Elsevier Inc. All rights reserved.IntroductionCraniosynostosis or premature suture fusion is a wide spread
disorder occurring in 300–500 out of 1,000,000 live births. In humans,
premature closure of cranial base synchondroses or sutures followed by
reduced growth of the skull along the rostral–caudal axes has been
implicated in both syndromic and single suture craniosynostoses.
Presence of multiple cases within a family and prevalence of cranio-
facial defects involving skull base growth in certain ethnic groups
strongly suggest a contribution of a genetic component to determina-
tion of craniofacial morphology (Singh, 1999). Thus, identiﬁcation of
candidate genes that regulate development and postnatal growth of the
craniofacial skeleton is important for further understanding of the
mechanism underlying skull abnormalities. Moreover, characterization
of molecular pathways involved in suture growth would facilitate the
design of biologically based treatments, which can substitute or
complement currently available surgical procedures. In the present
study, we have studied mechanisms of craniofacial bone and skull base
growth in conditional knockout mouse strains of polycystin-1 (Pkd-1).
The gene encoding polycystin-1, PKD1, was ﬁrst identiﬁed by
positional cloning as a gene mutated in 85% of patients with autosomal
dominant polycystic kidney disease (ADPKD) and its role in renal
pathology and kidney development has been intensively studied (The
European Polycystic Kidney Disease Consortium, 1994). Polycystin-1 isOlsen).
l rights reserved.an integral membrane glycoprotein with a large extracellular domain,
proposed to mediate intercellular and cell-matrix interactions. The
small intracellular domain has been implicated in signal transduction
by activating downstream cytoplasmic effectors (Delmas, 2005).
Together with anothermembrane-associated protein, the non-selective
cation channel polycystin-2, polycystin-1 mediates mechanosensory
signal transduction in renal epithelial cells (Nauli et al., 2003). In mice,
Pkd1 is broadly expressed in non-renal tissues (Guillaume et al., 1999)
and multiple developmental defects, including skeletal and vascular
abnormalities, were reported in Pkd1-deﬁcient animals. However, the
early onset of cyst formation in several internal organs and severe
systemic edema resulting in embryonic death obscured the interpreta-
tion of other phenotypic anomalies and prevented the analysis of
postnatal skeletal functions of polycystin-1 (Boulter et al., 2001; Kim et
al., 2000; Lu et al., 2001, 1997).
In this study, we usedWnt1-, Dermo1- and Osx1-Cre to conditionally
remove polycystin-1 from most skeletal tissues in mice. The data
demonstrate that polycystin-1 is a positive regulator of skeletal mesen-
chymal cell proliferation in cranial growth regions. Thus, Pkd-1 deﬁ-
ciency leads to premature closure of the synchondroses at the skull base
and impaired postnatal growth of dermal craniofacial bones.
Materials and methods
Mouse strains
Mice harbouring ﬂoxed alleles of Pkd1 were described previously
(Starremans et al., 2008). Dermo1-Cre, Wnt1-Cre and Osx-Cre deleter
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McMahon. The presence or absence of the Cre transgenes was
determined using PCR with primers speciﬁc to the Cre recombinase
coding sequence: Cre5′ (TGC TCT GTC CGT TTG CCG) and Cre3′
(ACT GTG TCC AGA CCA GGC).
Skeletal staining and parafﬁn section preparations
Skin, muscles and visceral organs were removed from embryos
or newborn animals prior to overnight incubation in solution con-
taining 0.06% Alizarin red S and 0.02% Alcian blue (Sigma, St. Louis,
MO) in a 1:4 mixture of glacial acetic acid and 95% ethanol. Skeletal
samples were then cleared by incubation in 1.8% and 0.3% potas-
sium hydroxide and stored in 100% glycerol. The skeletal prepara-
tions were analysed and photographed in glycerol/ethanol solution.
For histological analysis and in situ hybridisation on parafﬁn sections,
skull preparations were ﬁxed overnight in 4% paraformaldehyde
in PBS, dehydrated in ethanol and embedded in parafﬁn. Parafﬁn
blocks were sectioned at 6 μm, sections mounted onto glass slides,
de-waxed and processed for hematoxylin and eosin staining or in situ
hybridisation.
Frozen section preparation and β-galactosidase staining
Skulls of 4-day old pups were dissected and ﬁxed on ice in 4%
paraformaldehyde in PBS for 30 min, incubated overnight with
20% sucrose in PBS and embedded in Tissue-Tek OCT compound
(Sakura Finetek USA, Inc., Torrance, CA) with a slurry of solid CO2
in 95% ethanol. Frozen blocks were sectioned 7 μm thick using
Leica cryotome and air-dried for 30 min. After two washes in 10 mM
MgCl2 in PBS, samples were treated in detergent for 10 min on
ice and stained in solution containing 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6 3H2O, 1 mM MgCl2, 0.01% sodium deoxycholate, 0.009%
NP40, 1 mg/ml X-gal for 45 min to 3 h at 37 °C. Colour reaction was
stopped by postﬁxation in 4% paraformaldehyde in PBS for 30 min at
RT.
In vivo labelling of bone tissue
Calcein (6 mg/kg body weight) and alizarin complexon (60 mg/kg
body weight) were administered intraperitoneally postnatal day 4
and 2 h prior to sacriﬁce on postnatal day 14, respectively. Crania
were harvested for analysis, ﬁxed with 4% paraformaldehyde for 2 h
at RT and dehydrated in a series of graded alcohols. Individual cranial
bones were dissected out and mounted on slides using EUKITT
mounting medium (Electron Microscopy Sciences, Hatﬁeld, PA). The
sectionswere examined using a conventional (80i UprightMicroscope,
Nikon, Japan) or confocal (C1, Nikon, Japan) ﬂuorescence microscopes.
Images were obtained and analysed using Metamorph 7.0 and EZ-C1
software.
BrdU, phospho-histone 3, TUNEL staining and in situ hybridisation
BrdU (Sigma, St. Louis, USA) was injected intraperitoneally at
concentration 50 μg/g body weight 2 h before sacriﬁce. Skeletal tissue
of interest was harvested, ﬁxed overnight at 4 °C in 4% paraformalde-
hyde and decalciﬁed in 0.5 M EDTA for 2 weeks. Decalciﬁed samples
were embedded in parafﬁn and sectioned 6 μm thick. BrdU-positive
cells were detected using BrdU staining kits (Zymed Laboratories Inc.,
San Francisco, CA). Apoptotic cells were visualized using DeadEnd™
Fluorometric TUNEL system (Promega Corporation, Madison, WI).
Phosphorylated histone H3-speciﬁc antibodywas purchased from Cell
Signalling Technology (Beverly, MA) and used for immunocytochem-
ical experiments in accordance with the manufacturer’s recommen-
dations. In situ hybridisation was performed as described previously
(Kolpakova-Hart et al., 2007).Western blotting
Frontonasal suture and osteogenic front tissue were dissected and
cells separated from the extracellular matrix during a 4 h incubation
with collagenase P (1 mg/ml, Roche), and 0.01% trypsin at 37 °C. Cell
suspension was put through a 70 μm cell strainer (BD Falcon) and
lysed in ice-cold RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 2 mM
EDTA, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS) supplemented with
proteinase inhibitors. Aliquots of cell lysates (60 μg) were separated on
10% sodium dodecyl sulfate-polyacrylamide gels and transferred to
nitrocellulose membranes. The membranes were blocked with 5%
dry fat-free milk in PBS for 1 h and incubated overnight at 4 °C with
primary antibody in Tris-buffered saline (TBS) and 0.1% Tween 20.
Membranes were washed and incubated with secondary antibody
conjugated to horseradish peroxidase (Pierce,1:5000). Signal detec-
tion was performed using the Super Signal West Femto Maximum
Sensitivity Substrate (Pierce, Rockford, IL). The p-p38 MAPK (#9211)
and p-Erk1/2 (#4376) antibodies were from Cell Signaling and used at
dilution 1:1000. p21-speciﬁc antibody was obtained from Santa Cruz
(1:500; C19, sc-397).
Results
Genetic inactivation of Pkd1 results in delayed ossiﬁcation, malocclusion,
skull base synostosis and retarded postnatal growth of the craniofacial
complex
Cranial neural crest cells (NCC) contribute extensively to the neck
and anterior skeleton of the head, whereas the skeletal elements in
the posterior skull, trunk and limbs are derived from somitic and
lateral plate mesoderm. NCC-speciﬁc gene targeting using Wnt1-
driven Cre recombinase (Brault et al., 2001) has been employed in
several studies of craniofacial development (Brewer et al., 2004;
Dudas et al., 2004). To investigate a role of polycystin-1 in the cranial
neural crest mesenchyme, we performed Pkd1 inactivation by crossing
the Wnt1-Cre transgenic animals with Pkd1 ﬂoxed mice. Conditional
Wnt1-Cre; Pkd1 knockout mutants were born in Mendelian ratio and
appeared normal. However, a delay in intramembranous ossiﬁcation
of the skull was observed (Fig. S1A). Three weeks after birth, mutant
animals could be distinguished from their control littermates by a
shortened snout and a dome-shaped skull vault (Figs. 1A and B). In
addition, the growth of the upper jaw was profoundly retarded
leading to an abnormal apposition of the incisors (class III malocclu-
sion) (Fig. 1B). Preparations of the individual cranial bones from adult
mutant mice revealed that the frontal bones and mandible were only
slightly affected, whereas the nasal, premaxillary and maxillary bones
were severely reduced in length (Fig. 1C). Analysis of the cranial base
revealed that the most anterior synchondrosis (presphenoid, PSS) was
obliterated in the mutant animals, leading to shortening of the
sphenoid and presphenoid bones (Fig. 1D). The sphenooccipital
synchondrosis (SOS) remained patent in both mutants and their
wild-type littermates.
To visualize neural crest-derived skeletal tissue in the postnatal
skull, we crossed Wnt1-Cre mice with the conditional LacZ reporter
mouse strain Rosa 26R, in which β-galactosidase expression is
activated by Cre recombinase (Soriano, 1999). Analysis of the skull of
the Wnt1-Cre; R26R animals at postnatal day 4 suggested that con-
tribution of the neural crest cell population to the cranial base was
restricted to its anterior part, as only the presphenoid and sphenoid
bones were Wnt1-Cre positive. The anterior cranial base suture, the
presphenoid synchondrosis, consisted entirely of β-galactosidase-
positive cells, whereas no activity of the enzyme was detected within
the posterior sphenooccipital synchondrosis (Fig. S1B).
We next investigated the potential role of polycystin-1 in a broad
range of osteochondroprogenitor cells in the cranial, axial and appen-
dicular skeleton using Cre recombinase regulated by the promoter of
Fig. 1. Neural crest-speciﬁc inactivation of Pkd1 results in impaired postnatal growth of the rostral craniofacial skeleton and malocclusion. (A) Exterior morphology of wild-type and
conditional Wnt1-Cre; Pkd1mutants at weaning. (B) Alizarin red and Alcian blue staining of control and mutant skulls reveals a maxillary retraction and underbite (arrow) in Pkd1-
deﬁcient mice. (C) Comparative morphological studies of individual craniofacial bones from adult wild-type andWnt1-Cre; Pkd1mutant littermates stained with alizarin red reveal a
mild longitudinal growth defect of the mutant mandible and frontal bone in contrast to the severely affected growth of the nasal and premaxillary bones. (D) Early postnatal
obliteration of the presphenoid synchondrosis (arrow) in Pkd1-deﬁcient mice results in the shortening of the sphenoid bones (double-headed arrows). Mut—Wnt1-Cre; Pkd1/Pkd1,
WT—Wnt1-Cre; Pkd1/+.
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Dermo1 (Yu et al., 2003). Dermo1-Cre deleter mice have been
previously characterized (Yu et al., 2003) and successfully used for
gene targeting in skeletal tissues (Day et al., 2005; Kolpakova-Hart et
al., 2007; Yu et al., 2003). At birth, the Dermo1-Cre; Pkd1 animals
displayed a delay in ossiﬁcation of the cranial, axial and appendicular
skeleton (data not shown). In addition, mutant pups often displayed
slow growth and reduced body weight. A close examination of
conditional knockout animals revealed development of multiple cysts
in the kidney (Fig. S2A). During development, kidneys originate from
the intermediate mesoderm, localized between the somites and the
lateral plate (Saxen and Sariola, 1987). Using the Rosa reporter strain,
we conﬁrmed that Dermo1-Cre is expressed in the mesoderm-derived
kidney epithelium and interstitial mesoderm (Fig. S2B). Therefore, the
polycystic kidney phenotype observed in the Dermo1-Cre; Pkd1 mice
was due to kidney-speciﬁc Pkd1 inactivation. However, all Dermo1-
Cre; Pkd1mutants displayed a characteristic dome-shaped skull, indi-
cating defects in the postnatal growth of the cranial bones (Fig. 2A).
Upon close examination of the mutant skull base, we observed an
ossiﬁed bridge within the central area of the SOS (Fig. 2B). In order tounderstand the origin of this postnatal growth defect, we compared
the developmental changes within the prospective SOS in the control
and mutant embryos.
During embryogenesis, the presumptive SOS is formed after the
pituitary gland becomes separated from the roof of the mouth. In the
cranial base, it is located between two patches of undifferentiated
mesenchyme: hypophyseal and basicranial fenestrae, which are
normally present in the early embryonic chondrocranium, but
disappear as they become populated with skeletogenic tissue before
birth. In the Pkd1-deﬁcient skulls, the cranial base fenestrae were
found abnormally enlarged (Fig. 2C) and persisted during late
embryogenesis and after birth. In vivo double labelling of bone tissue
with calcein/alizarin demonstrated that ectopic ossiﬁcation of SOS in
Dermo1-Cre; Pkd1 mice impairs the postnatal longitudinal growth of
the cranial base (Fig. 2D). Closure across SOS was progressive with age
and a complete fusionwas observed in all adult mutant mice (Fig. 2E).
Similar to Wnt1-Cre; Pkd1 conditional knockout mice, premature
closure of the presphenoid synchondrosis within the ﬁrst postnatal
week was observed in Dermo1-Cre; Pkd1 mutant pups (Fig. S2C, left
panel). Thus, unlike Wnt1-Cre; Pkd1 mutants in which only PSS
Fig. 2. Reduced postnatal growth of the caudal neurocranium and the cranial base in Dermo1-Cre; Pkd1 mice. (A) Representative radiograph of control and Dermo1-Cre; Pkd1 skulls
(lateral view) shows the dome-shaped neurocranium, a characteristic feature of the Dermo1-Cre; Pkd1 mutant mice. (B) Ventral view of the cranium from 5-day old control and
mutant mice. In the Pkd1 knockout mice, an ossiﬁed contract is formed in the sphenooccipital synchondrosis (SOS) (arrow) and the presphenoid synchondrosis (PSS) is greatly
reduced in size (arrowhead). (C) Alizarin red and Alcian blue staining of the E18.5 skulls demonstrates a wide open basicranial (arrow) and hypophyseal (arrowhead) fenestrae in the
mutant cranial base. (D) Premature ossiﬁcation of the sphenooccipital synchondrosis (arrow) impairs longitudinal growth of the cranial base. Double calcein/alizarin complexon in
vivo labelling shows decreasedmineralization of the sphenoid and basisphenoid bones (brackets) between P5 and P12. (E) Dorsal view of the skull base fromwild-type and knockout
adult mice reveals a reduced length of the basisphenoid and basioccipital bones (double-headed arrows) in Dermo1-Cre; Pkd1 mice. The presphenoid and sphenooccipital
synchondroses are closed in the mutant, whereas they remain patent in control mice. Bo—basioccipital bone, Bs—basisphenoid bone.
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cranial base of the Dermo1-Cre; Pkd1 animals. That is in agreement
with the observation that Dermo1-Cre is expressed in both synchon-
droses and is not restricted to neural crest mesenchyme (Fig. S2C, right
panel).
Pkd1-deﬁcient synchondrosal chondrocytes and chondroprogenitor cells
exhibit reduced proliferative activity
Normal embryonic and postnatal growth of the skull base largely
depends on a ﬁne balance between proliferation and differentiation of
chondrocytes in the cranial base sutures (i.e. synchondroses). Upon
visual inspection, no morphological difference was observed between
newbornWnt1-Cre; Pkd1mutants and control littermates. By day four
after birth, the ﬁrst changes in the mutant anterior cranial base were
detected and manifested in diminished size of the presphenoid syn-Fig. 3. The distribution of the growth plate markers in theWnt1-Cre; Pkd1 presphenoidal syn
control and mutant cranial base at P4 demonstrates a reduction in length of the Pkd1-deﬁcie
mutant PSS at P6 shows premature closure for the mutant synchondrosis. (C–E) Expression
visualized by in situ hybridisation shows no strong differences.chondrosis (Fig. 3A). Within the next 2 days, the synchondrosal area
occupied by proliferating and resting chondrocytes was limited to a
small circular patch of cells surrounded by hypertrophic chondrocytes.
Eventually, remnants of the growth plate were displaced dorsally and
the synchondrosis was substituted by bone (Fig. 3B).
The cranial base growth deﬁciency in the absence of Pkd1 could be
caused by abnormal differentiation of synchondrosal growth plates,
decreased survival and/or proliferation of chondrocytes. To test these
possibilities, we analysed the distribution of collagen X, a speciﬁc
extracellular matrix protein produced by chondrocytes as they
differentiate and become hypertrophic. The expression of this marker
was restricted to the periphery of the mutant and control synchon-
droses, the typical location for hypertrophic chondrocytes within a
growth plate (Fig. 3C). Spatial distribution and expression levels of
type II collagen, osteopontin, type I collagen and Indian hedgehog
were not changed (Figs. 3D, E and data not shown).chondrosis is normal prior to its closure. (A) H&E staining of the parasagittal sections of
nt PSS prior to its closure. (B) H&E staining of the transverse sections of the control and
pattern of the type X (C), type II (D) and Osteopontin in the P3 control and mutant PSS
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vivo BrdU labelling and immunostaining on parafﬁn sections. The
number of dividing cells in the proliferative zone of the mutant PSS
was markedly decreased (Fig. 4A). We did not observe differences in
BrdU labelling between the mutant and control SOS (data not shown).
These results suggested that proliferative activity of chondrocytes
within the presphenoid synchondrosis was altered, causing the
premature closure of PSS and limited postnatal growth of the
basisphenoid and presphenoid bones. Similar observations were
made during the PSS closure of in Dermo1-Cre; Pkd1 mice (data not
shown).
To assess cell viability, we also performed TUNEL staining of
the affected synchondrosis prior to its fusion. We did not detect
any apoptosis in the mutant or control chondrocytes. However, we
observed a population of apoptotic cells in the perichondrium of
the mutant PSS prior to its closure, suggesting that polycystin-1
might be essential for survival of perichondrial cells (Figs. 4B
and C).
In order to understand the developmental defects that cause
the postnatal ossiﬁcation of the sphenooccipital synchondrosis in
Dermo1-Cre mice, we further examined skeletal preparations and
histology of the skull base in E12.5–E15.5 embryos. Invariably, the
cellularity and the overall thickness of the skull base were reduced
in the Pkd1 mutants at all embryonic stages (Fig. 5A). At E13.5
control embryos, the skull base area underlying the newly formed
pituitary gland was already occupied by fully differentiated
chondrocytes, whereas the corresponding region in the mutants,
was populated by undifferentiated mesenchymal cells (Figs. 5A and
B). In addition to delayed differentiation, the mesenchymal cells
that occupied the presumptive SOS area displayed decreasedFig. 4. Pkd1-deﬁcient presphenoid synchondrosis is characterized by a reduced proliferation
example of BrdU-speciﬁc staining of P3 presphenoid synchondrosis in control and Wnt1-Cre
Pkd1-deﬁcient (white bar) PSS chondrocytes is shown as average percent of BrdU-positive c
(right panel). (B) TUNEL staining of the control and Pkd1-deﬁcient presphenoid synchondro
(arrowheads). (C) High magniﬁcation of the single layer of apoptotic cells in the perichondrproliferative activity, as measured by BrdU incorporation (Figs. 5B
and C).
Interstitial and endochondral growth of the nasal septum is normal in
Wnt1-Cre; Pkd1 mice
To understand the nature of the growth defect of the upper
jaw observed in Wnt1-Cre; Pkd1 mice, we ﬁrst compared the post-
natal growth of the cartilaginous nasal septum and the ethmoid
bone, which support the craniofacial skeleton in the mid-line.
Levels of interstitial chondrocytic proliferation in the nasal septum
were evaluated using immunohistochemical labelling of phos-
phorylated histone 3 and BrdU incorporation. No signiﬁcant differ-
ences were detected between the Pkd1-deﬁcient and control nasal
cartilages at postnatal day 2, when the interstitial proliferation
normally occurs (Fig. 6A). Moreover, we did not observe cell death
or evidence of decreased secretion of the extracellular matrix by
chondrocytes later during the elongation of the nasal cartilage (data
not shown).
We next examined whether endochondral growth of the ethmoid
bone, which is continuous with the caudal nasal septum and
contributes to the anterior–posterior elongation of the upper jaw, is
affected by polycystin-1 inactivation. Differential in vivo double
labelling of the newly formed bone, did not reveal any difference in
the growth rate of mutant and control ethmoid bones between
postnatal days 4 and 14 (Fig. 6B). During the ﬁrst 2 weeks after birth,
the mutant nasal cartilage continued to increase in length, but its
advancement in the rostral direction was impaired due to the lack of
nasal bone growth. This led to a characteristic bent morphology of the
nasal septum and its displacement from the mid-line in all knockoutof chondrocytes and increased apoptosis of the perichondrial cells. (A) Representative
; Pkd1 cranial base (left and middle panels). Proliferative rate of control (black bar) and
ells relative to total cell population (n=5). All error bars are s.d., Pb0.01, Student's t test
sis prior to its obliteration reveals cell death within the perichondrium of the mutant
ium of the mutant PSS as its closure proceeds.
Fig. 5. Proliferation of the mesenchymal osteochondroprogenitor cells and chondrocytes is greatly reduced in the cranial base of Pkd1-deﬁcient embryos. (A, B) Parasagittal sections
from E13.5 wild-type and Dermo1-Cre; Pkd1 cranial base stained with H&E (A) or BrdU-speciﬁc antibody and nuclear Hoechst dye. Reduced cellularity and decreased proliferative
activity are evident in the cranial base of the Pkd1 conditional knockout embryos. (C) Quantitative analysis of the proliferative rate of the mesenchymal and chondrocytes in
the presumptive SOS region of the E13.5 control (black bar) and mutant (white bar) cranial base. (n=12). Error bars are s.d. Statistical signiﬁcance was determined by Student's t test.
Br—brain, OC—oral cavity, Pi—pituitary gland.
413E. Kolpakova-Hart et al. / Developmental Biology 321 (2008) 407–419pups (Fig. 6C). These data indicate that the morphological changes
detected in nasal cartilage by the second postnatal week are
secondary to the facial bone growth defect.
Postnatal growth of the posterior nasal and premaxillary bones is
impaired due to reduced proliferation of the sutural osteoprogenitor cells
Using the method of in vivo double labelling of bone tissue with
calcein and alizarin, we evaluated the postnatal growth of the nasal
bone during the ﬁrst 2 weeks after birth. At postnatal day 4, the
mutant and control nasal bones were comparable in shape and size,
albeit a markedly reduced bone matrix deposition was evident in the
mutant dermal bones at that stage (Fig. 6D, middle panel). Ten days
later, mineralization occurred in both rostral and caudal directions in
the control nasal bone (Fig. 6D, top left and right panels). Growth of
the rostral nasal bone proceeded normally in mutant mice as well,
whereas the elongation of its caudal part was signiﬁcantly reduced(Fig. 6D, bottom left and right panels). The growth of the premaxillary
bone was also affected but to a lesser degree.
Sutures of dermal bones are composed of mesenchymal cells and
serve as growth sites of the cranium. In order to understand the nature
of the growth defect observed in the Pkd1-deﬁcient facial bones, we
examined histological sections of the early postnatal frontonasal (FN)
and fronto-premaxillary (FP) sutures. Despite differences in the
overall morphology between the frontonasal and fronto-premaxillary
sutures, they both appeared as bands of mesenchymal cells, which
separate the osteogenic fronts of the adjacent bones. Histological
studies revealed no premature suture closure, as both FN and FP
sutures remained patent in control and mutant animals (data not
shown). To evaluate proliferative activity of the sutural osteoprogeni-
tor cells, BrdU labelling of the mesenchymal cells was performed. In
control mice, most BrdU-positive cells were detected within the
osteogenic fronts of the nasal and premaxillary bones (Fig. 7A, upper
panel). Fewer dividing cells were found in locations adjacent to
Fig. 6. Wnt1-Cre; Pkd1 mice display normal proliferation and endochondral ossiﬁcation of nasal septum, but reveal retarded growth of the caudal nasal bone. (A) Phosphorylated
histone 3 labelling of the nasal cartilage (outlined) demonstrates a comparable level of interstitial chondrocytic proliferation in the mutant and control pups. (B) In vivo calcein and
alizarin complexon double labelling of bone tissue deposited on postnatal day 4 (green) and day 14 (red) demonstrates that the endochondral growth of the ethmoid bone is not
affected by Pkd1 inactivation, as its mineralization rate (double-headed arrows) is similar in theWnt1-Cre; Pkd1 and control littermates. (C) Impaired nasal bone growth in the Pkd1
knockout mice results in lateral dislocation of the nasal cartilage (arrow). Arrowheads mark the limits of the ethmoid bone. (D) In vivo calcein/alizarin double labelling of bone
deposited on postnatal day 4 (green) and day 14 (red) shows normal growth of the mutant and wild-type rostral nasal bone (left panels, double-headed arrows). In contrast,
mineralization of the caudal nasal bone is markedly reduced in the Pkd1-deﬁcient mice relative to control (right panels, double-headed arrows). Note a delay in postnatal
intramembranous ossiﬁcation evident in the nasal mutant bone relative to control (central panels). E—ethmoid bone, N—nasal bone.
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liferating cells can be due to the fact that the frontal bone grows at a
slower rate in comparison to the nasal and premaxillary bones. A
limited number of proliferating cells was detected in the mutant
frontonasal suture, whereas the population of BrdU-positive cells in
the fronto-premaxillary suture was signiﬁcantly reduced (Figs. 7A
and B).
Conceivably, the growth abnormalities observed in the Pkd1-
deﬁcient cranial sutures could be due to proliferation or differen-
tiation defects in osteoblastic cells rather than in mesenchymal
osteoprogenitor cells. In order to test this possibility, we inactivated
Pkd1 in early osteoblastic cells using Cre recombinase driven by
Osterix-speciﬁc promoter (Rodda and McMahon, 2006). The Osx-Cre;
Pkd1 conditional knockout mice displayed a delay in intramem-
branous ossiﬁcation, but no growth defects of the craniofacial bones.
The length of the mutant nasal and premaxillary bones was com-
parable to control bones, suggesting that the craniofacial bone growth
deﬁciency observed in Pkd-1mutants was not due to defective osteo-
blasts (Fig. S3 and data not shown).
Up-regulation of Erk1 and Erk2 activity in Pkd1-defﬁcient
osteoprogenitor cells
We also attempted to gain insight into the mechanism by which
polycystin-1 may control proliferation of osteochondroprogenitor
cells. We dissected frontonasal and fronto-premaxillary suture cells
from Wnt1-Cre; Pkd1 mutant mice and their normal littermates at
P10–P12 and performed Western blot analyses with antibodies
against phospho-p38 MAPK, Erk1/2, phospho-Erk1/2, Akt, phospho-Akt and cell-cycle inhibitor p21 (Fig. 7C and data not shown). We
found no difference in p21 protein levels between osteoprogenitor
cells fromwild-type and Pkd1-deﬁcient mice. Comparable amounts of
Akt were present in both control and Wnt1-Cre; Pkd1 animals,
whereas the phosphorylated form of Akt was undetectable (data not
shown). Phosphorylation of p38 MAPK was not affected by Pkd-1
inactivation. In contrast, Pkd1-deﬁciency in suture cells resulted in
signiﬁcantly increased levels of phosphorylated Erk1/2 (Fig. 7C).
Directional orientation of collagen ﬁbers in frontonasal vs.
fronto-premaxillary sutures is spatially related to the proliferation of
osteoprogenitor cells
Different craniofacial sutures in mice display distinct morphology.
The frontonasal suture is straight, as opposed to the highly inter-
digitated, zigzag-shaped fronto-premaxillary suture. Previous studies
in several mammalian species suggest that the morphology of the
cranial sutures correlates with the polarity and magnitude of the
mechanical forces acting on cells within a suture. It has been
predicted that blunt-ended sutures result from tension, whereas
interdigitated sutures are associated with compressive forces. Accor-
dingly, two different types of collagen ﬁber arrangement have been
suggested: straight orientation of ﬁbers for tensed sutures and
oblique orientation for compressed sutures (Rafferty and Herring,
1999).
Using confocal ﬂuorescence microscopy we analysed the organiza-
tion of the collagen ﬁbers in the FN and FP sutures. We found the ﬁber
pattern to be consistent with the prediction for both sutures. The FN
displayed morphology of a tensed suture with straight collagen ﬁbers
Fig. 7. Pkd1-deﬁcient facial bones display reduced proliferation of the sutural mesenchymal cells, yet Erk1 and Erk2 phosphorylation is up-regulated. (A) BrdU-positive cells are
observed at the osteogenic fronts in the frontonasal (top left panel) and the fronto-premaxillary (top right panel) wild-type sutures. In Pkd1 knockout mice, proliferation of the
mesenchymal cells is undetectable in the frontonasal suture, whereas cell division in the fronto-premaxillary suture is signiﬁcantly reduced. F—frontal, N—nasal, P—premaxillary
bone. (B) Proliferative rate of control (black bars) and Pkd1-deﬁcient (white bars) sutural cells is shown as average percent of BrdU-positive cells relative to total cell population (n=10
for frontonasal suture, n=12 for fronto-premaxillary suture). All error bars are s.d., Pb0.001, Student's t test. (C) Expression levels of p21 and the phosphorylated form p38 MAPK are
not affected in Pkd1-null sutures, whereas the Erk1/2 activity is elevated.
415E. Kolpakova-Hart et al. / Developmental Biology 321 (2008) 407–419stretching across the sutural tissue (Fig. 8A, left panel). In contrast, the
FP suture appeared to be a largely compressed suture with obliquely
arranged collagen ﬁbers, which provide the best mechanism to resist
compression (Fig. 8A, right panel).
Interestingly, even within the highly compressed FP suture, there
were sites with collagen ﬁbers organized in a manner consistent with
the presence of tensile forces. These sites coincided with the locations
of active proliferation and directional bone deposition (Fig. 8B). In the
frontonasal suture from the wild-type mice, proliferating cells were
concentrated around the osteogenic fronts of the fast-growing nasal
bone (Fig. 8C, left panel). The osteogenic fronts of the growth-retarded
Pkd1-deﬁcient frontonasal suture appeared blunt-ended with few
BrdU-positive cells present (Fig. 8C, right panel).
Discussion
Coordinated growth of cranial bones is essential for accommodat-
ing the embryonic and postnatal expansion of the brain. Traditionally,calvarial sutures have been considered as major growth sites of the
mammalian skull (Ogle et al., 2004; Opperman, 2000). However, the
cranial base, occupying the ventral part of the skull and serving as a
supportive platform for the mid-facial skeletal structures, also
contributes to the growth of the head skeleton. Furthermore, a
coordinated growth of craniofacial bones is important for establishing
the proportional spatial relationship between the lower and upper
jaws and leads to malocclusion when disturbed.
Multiple synchondroses, which separate bones of the skull base,
serve as growth sites during base expansion. Morphologically, a
synchondrosis appears as two opposing cartilage growth plates.
Analogous to endochondral growth plates in long bones, synchon-
droses of the skull base grow through a combination of chondrocyte
proliferation and hypertrophy. In mice, both the presphenoid and
sphenooccipital synchondroses remain patent even in adults. Similar
to the epiphyseal growth plate in the long bones, adequate prolifera-
tion, differentiation and maturation rates of chondrocytes within the
synchondroses are required for longitudinal growth of the cranial
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regulating the postnatal growth of the cranial base. Thus, genetic
ablation of the latent TGF-β binding protein (Ltbp-3), an extracellular
matrix molecule that regulates the bioavailability of TGF-β, results in
obliteration of the cranial base synchondroses, a dome-shaped skull
and malocclusion (Dabovic et al., 2002b,a). However, the mechanism
bywhich Ltbp-3 controls postnatal growth of the synchondroses mustbe distinct from that of polycystin-1 as premature hypertrophy rather
than reduced proliferation of chondrocytes was reported in Ltbp-3
knockout mice. Inactivation of Fgfr2 also leads to obliteration of the
cranial base synchondroses, overgrowth of low incisors and a dome-
shaped skull phenotype (Eswarakumar et al., 2002). However, the
mechanism of the impaired synchondrosal growth in the Fgfr2-
deﬁcient mice was not characterized in detail.
417E. Kolpakova-Hart et al. / Developmental Biology 321 (2008) 407–419Our data demonstrate that skeletal tissue-speciﬁc Pkd1-deﬁciency
results in embryonic defects in the mesodermal sphenooccipital
synchondrosis and/or postnatal abnormalities in the neural crest-
derived presphenoid synchondrosis. InWnt1-Cre; Pkd1mice, only the
anterior cranial base synchondrosis (PSS) underwent premature clo-
sure, whereas the posterior suture (SOS) remained intact even in adult
animals. This is consistent with PSS being of neural crest origin. In
contrast, Dermo1-Cre, that drives Pkd1 inactivation in the entire
cranial base, causes synchondrosal defects in both PSS and SOS.
Prior to premature postnatal closure of the PSS, we did not detect
an early onset of hypertrophy in the mutant synchondroses, and the
distribution of the hypertrophic chondrocytes was normal (restricted
to the periphery of the growth plates). In contrast, we demonstrated a
decreased proliferation of chondrocytes. Although the growth
deﬁciency in the cranial base synchondrosis appears as a cell-auto-
nomous chondrocytic defect, we cannot exclude the possibility that
these abnormalities are a result of an indirect effect of the Pkd1-
deﬁcient perichondrium/periosteum where emergence of apoptotic
cells coincides with a decrease in chondrocytic proliferation.
Unlike the postnatal onset of the growth defect within the PSS,
abnormalities observed in the SOS of Dermo-Cre1; Pkd1 conditional
knockout mice are due to a speciﬁc embryonic defect spatially res-
tricted to the border between the neural crest and the paraxial meso-
derm. The presumptive SOS is formed in the location where the oral
ectoderm invaginates to form adenopituitary gland and is initially
composed of mesodermal chondroprogenitor cells. Between E12 and
E13.5, these cells proliferate and differentiate into chondrocytes, as
the prospective pituitary gland becomes separated from the roof of
the oral cavity. The Pkd1-deﬁcient embryos exhibited a signiﬁcant
decrease in proliferation of mesenchymal osteochondroprogenitor
cells in the cranial base. For the mutant prospective SOS, the
proliferation level was estimated to be 5-fold lower relative to control.
We also observed impaired differentiation of the mesenchymal cells
into chondrocytes in the SOS region, which might contribute to the
persistence and ossiﬁcation of the fenestra after birth. Despite the
differences in the tissue origin and nature of the defects, both PSS and
SOS abnormalities in Pkd1-deﬁcient mice lead to reduced postnatal
longitudinal growth of the cranial base.
Our data address the important question of what skeletal structure
is the primary growth centre of the anterior craniofacial complex.
Recently, it has been documented that shortly after birth the
cartilaginous nasal septum undergoes active interstitial proliferation
followed by rapid expansion in the rostral–caudal direction (Wealthall
and Herring, 2006). Normally, during the ﬁrst two postnatal weeks,
both the nasal septum and the nasal bone grow at a high and similar
rate. However, it remains unclear whether the expanding nasal
septum drives the growth of the surrounding nasal and premaxillary
bones. Alternatively, the nasal cartilage may only serve as mechanical
support for the craniofacial bones and passively follow their growth in
the antero-posterior direction. Because inactivation of Pkd1 in neural
crest cells does not affect proliferation of chondrocytes in nasal
cartilage, but does reduce the sutural growth of dermal bones, the
postnatal autonomous expansion of the nasal cartilage, which occursFig. 8. Collagen ﬁber organization, mesenchymal cell proliferation and directional bone de
sections through the frontonasal and fronto-premaxillary sutures in growingmice (P22). Low
type frontonasal and fronto-premaxillary sutures (P22) visualizes topology of collagen ﬁbers
collagen ﬁber bundles, whereas the fronto-premaxillary suture appears largely compressed
growing osteogenic fronts reveal presence of tensile forces in the suture (white arrows).
immunohistochemical labelling and BrdU-positive cells were artiﬁcially coloured in red. R
demonstrates that the sites of increasedmesenchymal cell proliferation coincide with the site
defﬁcient frontonasal sutures superimposed onto ﬂuorescense images of the osteoid and coll
tensile forces. Left panel: in a suture of growing craniofacial skeleton, extracellular matrix ﬁ
found in close contact with collagen ﬁbers where they are subjected to mechanical stress ap
growth-induced tension by increased proliferation of pre-osteoblastic cells resulting in an
osteoblasts relocates to osteogenic fronts of growing craniofacial bones and is responsible
growth.in Wnt1-Cre; Pkd1 mutant mice, even in the absence of nasal bone
growth, strongly suggests an intrinsic ability of the nasal septum to
actively contribute to mid-facial translation.
The nasal bone is exceptional in its high growth rate. The
arrangement of the collagen ﬁbers clearly demonstrates that the
frontonasal suture is subjected to tensile forces during growth of the
nasal complex. The premaxillary bone is likely to be affected by
multiple forces of opposite polarity. The fact that the incisors are
locatedwithin the premaxillary bone has an impact on themechanical
loading this bone is subjected to. The direct incisal bite applies a
compressive force on both premaxilla-maxillary and fronto-premax-
illary sutures. The interdigitated nature of fronto-premaxillary suture
and the oblique orientation of the collagen ﬁbers along its almost
entire surface reﬂect the presence of compressive loading. On the
other hand, the mechanical stress generated by eruption of incisors
and by the growth of the nasal septum is likely to exert tensile forces
on the premaxillary bone. Accordingly, straight collagen ﬁbers are
present along the actively growing tips of the bone.
Based on the analysis of the skull phenotype observed in Pkd1-
deﬁcient mice we hypothesize that tensile forces within the expand-
ing viscerocranium are necessary for the directional growth of dermal
bones and that polycystin-1 is an essential mediator of this process, as
it controls proliferation of the mesenchymal cells at the osteogenic
fronts. Using Wnt1-Cre; Pkd1 conditional knockout mice and the
technique of mid-palatal suture expansion (Hou et al., 2007), we have
tested this hypothesis. The results (Hou B. in preparation) demon-
strate that the Wnt1-Cre; Pkd1 mice display an impaired response to
tensile forces in vivo. In this system, induced mid-palatal suture
expansion in wild-type mice triggers proliferation, osteoblastic
differentiation of the osteoprogenitor cells within the suture and
new bone deposition. In contrast, Pkd1-deﬁcient mice exhibit delayed
and severely reduced proliferation and differentiation responses of
osteoblastic progenitor cells.
Recent in vitro studies have provided evidence that proliferation
and differentiation of chondrocytes and osteoprogenitor cells are
modulated bymechanical stress (Fitzgerald et al., 2006; Grodzinsky et
al., 2000; Kanno et al., 2007; Riddle et al., 2006). In rabbits, tensile
forces applied across the frontonasal suture by using an expandable
device results in lengthening of the craniofacial complex (Movassaghi
et al., 1995). Furthermore, in vivo cyclic and static loading of the
cranial base of growing rabbits, induced increased proliferation of
chondrocytes leading to an enlargement of the proliferative zone of
the cranial base synchondroses (Wang and Mao, 2002). However, the
molecular mechanism underlying the response of suture cells to
mechanical strain remains poorly understood. Our data indicate that
polycystin-1 is involved in the process ofmechanotransduction and/or
response during skull growth. The initial studies of the extracellular
domains found in polycystin-1 suggested that this protein canmediate
cell–cell and/or cell–extracellular matrix interactions (Hughes et al.,
1995). Forman et al. (Forman et al., 2005) used atomic force
microscopy to investigate the mechanical properties of the extra-
cellular PKD domains of polycystin-1 and showed that these domains
exhibited a remarkable mechanical strength. Based on the structuralposition in growing craniofacial sutures. (A) Upper panel: H&E staining of transverse
er panel: confocal single scanning images of H&E stained transverse sections of thewild-
and osteogenic fronts. The frontonasal suture displays a tension-speciﬁc arrangement of
with obliquely oriented collagen ﬁbers (red arrows). However, the suture areas around
(B) Left panel: BrdU staining of the fronto-premaxillary suture was performed using
ight panel: in vivo calcein-alizarin double labelling of the fronto-premaxillary suture
s of active bone deposition. (C) BrdU-positive cells visualized in the wild-type and Pkd1-
agen ﬁbers in the suture. (D) Postnatal growth of the craniofacial skeleton in response to
bers are stretched in response to tensile forces. Mesenchymal osteoprogenitor cells are
plied by growing nasal septum. Middle panel: mesenchymal cells in a suture respond to
increased number of differentiated osteoblasts. Right panel: enlarged population of
for the directional bone-speciﬁc extracellular matrix deposition and longitudinal bone
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have elastic properties, it has been proposed that the protein functions
mechanically by providing a ﬂexible and elastic linkage between cells
(Qian et al., 2005). Malhas et al. (2002) suggested that the leucine-rich
repeats (LRR) of polycystin-1 modulated the binding of the protein to
various ECM components, such as type I collagen, ﬁbronectin and
laminin. Interestingly, addition of the LRR fusion protein to cells
grown in culture resulted in a signiﬁcant dose-dependant reduction in
the rate of proliferation. Based on such ﬁndings and the experimental
data presented in this study, we propose a mechanism by which
polycystin-1 might regulate dermal bone growth. According to our
model, polycystin-1 displayed on the surface of sutural osteoprogeni-
tor cells interacts with collagen ﬁbers, which relay tensile forces
present within a suture. Osteoprogenitor cells, in turn, respond by
proliferation, osteoblastic differentiation and directional bone deposi-
tion (Fig. 8D).
The mechanism by which polycystin-1 regulates proliferation in
chondrocytes and osteoprogenitor cells remains to be elucidated.
Previous studies reported that Pkd1 may control cell proliferation
through AP-1 or STAT6-mediated pathways (Arnould et al., 1998; Low
et al., 2006; Parnell et al., 2002). It has also been suggested that
polycystin-1 and polycystin-2 regulate cell cycle by activating
transcription factor Id2 (Li et al., 2005). Pkd1-deﬁciency in kidney
resulted in increased proliferation and de-differentiation of tubular
epithelial cells. However, our data suggest that inactivation of
polycystin-1 in osteochondroprogenitor cells results in reduced
proliferation. In contrast to the reduced levels of p21 in kidney
epithelial cells lacking Pkd-1 (Bhunia et al., 2002), we could not detect
any difference in the expression of this cell-cycle regulator. Phosphor-
ylation of p38 MAPK was not affected by Pkd-1 inactivation. In
contrast, Pkd1-deﬁciency in suture cells resulted in signiﬁcantly
increased levels of phosphorylated Erk1/2. This is similar to what
was reported for polycystic kidney cells in rats and mice (Nagao et al.,
2003; Shibazaki et al., 2008). Thus, in both osteoprogenitor and renal
cells the presence of Pkd-1 is associated with reduced Erk1/2
phosphorylation; yet, the effects on proliferation are completely
different. In the craniofacial sutures, the presence of polycystin-1 is
associated with high proliferative activity; in the kidney, the presence
of the protein is, apparently, associated with low proliferative activity.
Differential cell-type dependent responses to extracellular stimuli
have been previously described for a variety of signalling pathways.
The outcome seems to largely depend on the repertoire of down-
stream effectors available in a given cell type. In agreement with this,
it has been shown that deﬁciency in polycystin-2, which is believed to
function together with polycystin-1, leads to reduced cell proliferation
of lymphoblastoid cells (Aguiari et al., 2004). However, it has also been
argued that Erk1/2 activation may not be the underlying basis for
increased proliferation observed in cyst-lining cells (Shibazaki et al.,
2008).
Recently, hyperactivation of Erk1/2 signalling pathway was linked
to premature closure of the coronal suture and cranial base growth
defects, caused by constitutively active Fgfr2 (Yin et al., 2008).
Moreover, inhibition of Erk1/2 signalling in vivo was reported to
prevent craniosynostosis induced by a similar activating mutation in
Fgfr2 (Shukla et al., 2007).
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